对比聚桂醇泡沫硬化剂与聚桂醇注射液在 内痔患者中的疗效及术后并发症.

Objective　To investigate the efficacy of lauromacrogol foam sclerosant and lauromacrogol injection in patients with internal hemorrhoids. Methods　A total of 94 patients with internal hemorrhoids treated in Kunming Second People’s Hospital from February 2020 to August 2021 were randomly selected and divided into study group and control group by number table method. The control group （n = 47）was treated with lauromacrogol injection，and the study group （ n = 47） was treated with lauromacrogol foam sclerosant. The total effective rate， clinical indicators （total course of treatment，operation cost，dosage of lauromacrogol ），intraoperative bleeding， postoperative pain and complications. Results　The total effective rate of the study group was higher than that of the control group，and the difference was statistically significant （P < 0.05）. The total duration of treatment，operation cost and dosage of lauromacrogol in the study group were lower than those in the control group，and the differences were statistically significant （P < 0.05）. The intraoperative local blood loss and postoperative pain in the study group were lower than those in the control group， and the differences were statistically significant （ P < 0.05） . The incidence of complications in the study group was lower than that in the control group， and the difference was statistically significant （ P < 0.05） . Conclusion　Lauromacrogol foam sclerosant is better than lauromacrogol injection in the treatment of patients with internal hemorrhoids，and can shorten the length of hospital stay，reduce the dosage of lauromacrogol，hospitalization costs，complications，and is worthy of promotion and application. [ABSTRACT FROM AUTHOR]